Notes
One of the investigators was affiliated with Korea Otsuka Pharmaceutical Co, Ltd.
Reference
Lee MY, et al. Cost-Effectiveness of Tolvaptan for Euvolemic or Hypervolemic Hyponatremia. Clinical Therapeutics : 20 Aug 2014. Available from: URL: http://doi.org/10.1016/j.clinthera.2014.07.010
Rights and permissions
About this article
Cite this article
Tolvaptan fits the bill for hyponatraemia in Sth Korea. PharmacoEcon Outcomes News 711, 31 (2014). https://doi.org/10.1007/s40274-014-1540-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1540-5